Yearly Archives: 2024

Multiplier Advisors and Tideline today announced a strategic partnership to support health-focused impact investors—such as healthcare organizations, insurers, and foundations—that are directing investable assets to address social determinants of health (SDOH) while targeting the alignment of financial, business, and community impact performance. Through this partnership, Multiplier and Tideline are aiming to unlock $5 billion of […]

Canary Speech and CareLink360 Form Partnership to Support Family Caregivers and the Aging Adults They Care For. Flemington, NJ – April 8, 2024 – Today we are excited to announce a new partnership between Canary Speech, an AI-driven vocal biomarker health company and CareLink360, a digital health, AgeTech, and data analytics insights company, to support family […]

The C-Blu team’s device provides greater visual contrast to potentially cancerous lesions, enabling improved accuracy for clinicians during the screening process. Despite a crowded field of over 30 other entries, the C-Blu team rose to the top to be named the Grand Prize Winner at the 14th Annual Bench to Bedside Competition on Monday night […]

VALENCIA, Calif. – April 10, 2024 – Nusano, a physics company transforming the production of medical radioisotopes, today announced it will attend and present at Jefferies Radiopharma Innovation Summit in New York City on Thursday, April 11, 2024. In his presentation, Nusano CEO Chris Lowe will provide an update on the company’s commercialization plans, including […]

Fewer patients were prescribed medications with gene-drug interactions after taking the GeneSight test SALT LAKE CITY, April 09, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, revealed results from a multi-year, real-world study of nearly 21,000 patients that indicated those with major depressive disorder had reduced […]

LONDON and SALT LAKE CITY, April 08, 2024 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces a registered direct offering of ordinary shares at a purchase price equivalent to $0.75 per NASDAQ ADS ($0.375 per common stock share) (£0.0025 each) (the “Ordinary Shares”) (the “Fundraise”) to DB Capital Partners Healthcare, L.P. (the “Purchaser”), […]

FRANKLIN LAKES, N.J., April 9, 2024 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will receive the Business Group on Health “Best Employers: Excellence in Health & Well-being Award” for its commitment to advancing employee well-being through comprehensive and innovative benefits and initiatives. BD also […]

ATLANTA–(BUSINESS WIRE)– Edwards Lifesciences (NYSE: EW) announced the release of data from the HUDDLE study that examined the prevalence of heart disease and associated risk factors among members of the National Football League (NFL) Alumni Association and their families. The findings of this study, which identified a significant discrepancy between participant self-awareness and actual prevalence […]

– Financing will support development of a foundational machine learning model of medicinal chemistry that can accurately predict small molecule drug candidates for any protein – – Releases unprecedented dataset publicly to address critical challenges in drug discovery with machine learning – SALT LAKE CITY, April 05, 2024 (GLOBE NEWSWIRE) — Leash Biosciences, an artificial […]